Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23872-55-1

Post Buying Request

23872-55-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23872-55-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 23872-55-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,7 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23872-55:
(7*2)+(6*3)+(5*8)+(4*7)+(3*2)+(2*5)+(1*5)=121
121 % 10 = 1
So 23872-55-1 is a valid CAS Registry Number.

23872-55-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-[(4-chloroanilino)methylidene]-1,3-diazinane-2,4,6-trione

1.2 Other means of identification

Product number -
Other names 5-[(4-chloro-anilino)-methylene]-pyrimidine-2,4,6-trione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23872-55-1 SDS

23872-55-1Upstream product

23872-55-1Downstream Products

23872-55-1Relevant articles and documents

Computer-aided design, synthesis, and biological evaluation of 5-substituted aminomethylenepyrimidine-2,4,6-triones as H1 antihistaminic agents(Part2)

Elbayaa, Rasha Y.

, p. 66 - 73 (2014/01/17)

As a part of a research project pertaining to the synthesis of novel candidates as nonsedating, nonclassic H1 histaminergic (H1) blockers with low toxicity profiles, some new 5-substituted aminomethylenepyrimidine-2,4,6-triones were designed based on the H1 histaminic receptor pharmacophore model. The interactions between the designed compounds and the H1 receptor were studied using molecular docking on the homology model of H1 receptor. The designed compounds were synthesized and biologically evaluated for H1-blocking activity; using isolated segments of guinea pig ileum. Compounds 15,18,19 and 21 exhibited comparable activities to acrivastine (22) as reference nonsedating drug. The C log P of designed compounds revealed lower values in reference to acrivastine (22) which might indicate decreased tendency for crossing the blood brain barrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23872-55-1